An anticancer agent, pyrvinium pamoate inhibits the NADH–fumarate reductase system—a unique mitochondrial energy metabolism in tumour microenvironments
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Increased glycolysis is the principal explanation for how cancer cells generate energy in the absence of oxygen. However, in actual human tumour microenvironments, hypoxia is often associated with hypoglycemia because of the poor blood supply. Therefore, glycolysis cannot be the sole mechanism for the maintenance of the energy status in cancers. To understand energy metabolism in cancer cells under hypoxia-hypoglycemic conditions mimicking the tumour microenvironments, we examined the NADH-fumarate reductase (NADH-FR) system, which functions in parasites under hypoxic condition, as a candidate mechanism. In human cancer cells (DLD-1, Panc-1 and HepG2) cultured under hypoxic-hypoglycemic conditions, NADH-FR activity, which is composed of the activities of complex I (NADH-ubiquinone reductase) and the reverse reaction of complex II (quinol-FR), increased, whereas NADH-oxidase activity decreased. Pyrvinium pamoate (PP), which is an anthelmintic and has an anti-cancer effect within tumour-mimicking microenvironments, inhibited NADH-FR activities in both parasites and mammalian mitochondria. Moreover, PP increased the activity of complex II (succinate-ubiquinone reductase) in mitochondria from human cancer cells cultured under normoxia-normoglycemic conditions but not under hypoxia-hypoglycemic conditions. These results indicate that the NADH-FR system may be important for maintaining mitochondrial energy production in tumour microenvironments and suggest its potential use as a no…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tomitsuka, Kita, and Esumi [11] compared its effects under hypoxic‐hypoglycaemic conditions, which mimics the tumour microenvironment (TME), and normoxia–normoglycaemic conditions and found that in PDAC, PP inhibits mitochondrial energy metabolism through the inhibition of the NADH‐fumarate reductase (NADH‐FR) system.”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [11]
In the citing paper
“PP was previously shown to be effective under conditions that mimic the PDAC TME [10, 11, 12]”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [11]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 1×
“The protein concentrations were estimated using the Bradford method (23).”
MethodParkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
(1989) · PubMed · Cited by 3,343
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Regulation of cellular metabolism by protein lysine acetylation
Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910 · cited 1×
“These observations raise two questions: how does PP affect complex II and how does complex II differ under normal and tumour microenvironmental conditions? Post-translational modifications in mitochondrial proteins, such as phosphorylation and acetylation, have been identified and some of these modifications regulate…”
BackgroundPINK1-dependent recruitment of Parkin to mitochondria in mitophagy
Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L. A., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911187107 · Cited by 1,616
Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., Saito, N., Ochiai, A., Tomita, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4806 · Cited by 956 · cited 1×
“Despite the limited glucose concentrations in tumour tissues in tumour microenvironments, the accumulation of amino acids has been observed in tumour tissues (3, 37).”
BackgroundSelf-citationTrounce, I. A., Kim, Y. L., Jun, A. S., & Wallace, D. C. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)64044-0 · Cited by 746
Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin
Ziviani, E., Tao, R. N., & Whitworth, A. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913485107 · Cited by 735
Cited by
Chinopoulos, C. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23196 · Cited by 143
“…as part of an entity termed the ‘‘NAD1-fumarate reductase system’’ has been reported to occur in bacteria, lower eukaryotes, shellfish, and cancer cells (Kroger et al., 1992; Kita et al., 2007; Tomitsuka et al., 2009, 2010, 2012) and is composed of complex I and the reverse reaction of complex II.”
BackgroundSenkowski, W., Zhang, X., Olofsson, M. H., Isacson, R., Höglund, U., Gustafsson, M., Nygren, P., Linder, S., Larsson, R., & Fryknäs, M. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0792 · Cited by 141
“Pyrvinium pamoate, also an anthelmintic drug, targets the fumarate-reductase systemandhasbeenpreviously recognized for its high activity against spheroids and glucose-deprived cells (32, 33).”
BackgroundROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway
Moskal, N., Riccio, V., Bashkurov, M., Taddese, R., Datti, A., Lewis, P. N., & Angus McQuibban, G. (2020) · Nature Communications · doi:10.1038/s41467-019-13781-3 · Cited by 142
Cancer Usurps Skeletal Muscle as an Energy Repository
Luo, Y., Yoneda, J., Ohmori, H., Sasaki, T., Shimbo, K., Eto, S., Kato, Y., Miyano, H., Kobayashi, T., Sasahira, T., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1052 · Cited by 112
Inaoka, D. K., Shiba, T., Sato, D., Balogun, E. O., Sasaki, T. G., Nagahama, M., Oda, M., Matsuoka, S., Ohmori, J., Honma, T., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160715287 · Cited by 113
Self-citation
Metadata
- Authors
- Tomitsuka, E., Kita, K., & Esumi, H.
- Affiliations
- National Cancer Centre Japan (JP)
- Corresponding author
- Tomitsuka, Eriko
- Venue
- The Journal of Biochemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-04-23
- Volume
- 152
- Issue
- 2
- Pages
- 171-183
- ISSN
- 0021-924X (ISSN-L)
- 1756-2651
- OpenAlex
- W2142261125
- Cited by
- 79
- References
- 50
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 8 · 2020: 10 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 12 · 2012: 1
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Hirosaki University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- pyrvinium pamoate, mitochondrial bioenergetics, tumor microenvironment, hypoxia, hypoglycemia, cancer cell energy metabolism, NADH-ubiquinone reductase, succinate-ubiquinone reductase, NADH oxidase, therapeutic target
- MeSH terms
- Animals, Hypoxia, Anthelmintics, Antineoplastic Agents, Cattle, Energy Metabolism, Enzyme Inhibitors, Humans, Hypoglycemia, Mitochondria, Mitochondria, Heart, Pyrvinium Compounds, Tumor Cells, Cultured, Cell Hypoxia, Ascaris suum, Electron Transport Complex II, Oxidoreductases Acting on CH-CH Group Donors, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An anticancer agent, pyrvinium pamoate inhibits the NADH–fumarate reductase system—a unique mitochondrial energy metabolism in tumour microenvironments. https://app.cochat.ai/papers/10.1093/jb/mvs041
- The paper
- Tomitsuka, E., Kita, K., & Esumi, H. (2012). An anticancer agent, pyrvinium pamoate inhibits the NADH–fumarate reductase system—a unique mitochondrial energy metabolism in tumour microenvironments. The Journal of Biochemistry. https://doi.org/10.1093/jb/mvs041
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.